NCT06795867 Acceptance and Commitment Therapy to Improve Disability in Chronic Migraine
| NCT ID | NCT06795867 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Brigham and Women's Hospital |
| Condition | Chronic Migraine |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-04-21 |
| Primary Completion | 2027-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2025-04-21 with a primary completion date of 2027-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn if the behavioral treatment called Acceptance and Commitment Therapy (ACT) works to improve disability in adults with chronic migraine. The main questions it aims to answer are: Does the use of ACT added to usual treatment improve scores on questionnaires designed to measure daily functioning and activity? Does the use of ACT added to usual treatment improve scores on diaries designed to measure headache frequency and pain? Researchers will compare adding ACT to usual headache treatments to usual headache treatments without ACT. Participants who are selected for ACT will take 8 classes to learn ACT and then will practice it at home, in addition to their regular headache treatment. Those not selected will continue their regular headache treatment. Four times over the following year, participants will answer questions about their symptoms during each of four virtual visits. They will also keep a daily headache diary during the study
Eligibility Criteria
Inclusion Criteria: * Willingness and ability to engage in the consent process * Willingness to participate in the study, despite randomization outcome * Availability for the duration of the study * Diagnosis of chronic migraine followed at the Graham Headache Center * Access to the necessary resources for participating in a technology-based intervention Exclusion Criteria: * Known major depression or other psychiatric condition * Non-English speaking * Secondary headache diagnosis * Psychotherapy in the prior 18 months * Any reason the provider feels would limit participant ability to learn or practice ACT * Any previous experience with mindfulness or meditation approaches
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06795867 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Chronic Migraine. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06795867 currently recruiting?
Yes, NCT06795867 is actively recruiting participants. Contact the research team at prizzoli@bwh.harvard.edu for enrollment information.
Where is the NCT06795867 trial being conducted?
This trial is being conducted at Boston, United States.
Who is sponsoring the NCT06795867 clinical trial?
NCT06795867 is sponsored by Brigham and Women's Hospital. The trial plans to enroll 40 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.